Sibyl Anderson

Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial

Bernard Escudier, Tim Eisen, Walter M. Stadler et al. · Journal of Clinical Oncology · 2009 · 1.1K citations · Full text

Medicine, Oncology, Cancer Pharmacology +8

Phase II Study of Doxorubicin and Bevacizumab for Patients With Metastatic Soft-Tissue Sarcomas

David R. D’Adamo, Sibyl Anderson, Karen Albritton et al. · Journal of Clinical Oncology · 2005 · 252 citations · Full text

Medicine, Oncology, Pharmacology +14

Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma

Mario M. Leitão, Robert A. Soslow, Daisuke Nonaka et al. · Cancer · 2004 · 163 citations · Full text

Medicine, Oncology, Pathology +17

Early Detection and Prognosis of Ovarian Cancer Using Serum YKL-40

Jakob Dupont, Meena K. Tanwar, Howard T. Thaler et al. · Journal of Clinical Oncology · 2004 · 137 citations · Full text

Medicine, Gynecology, Oncology +17

Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial

Tim Eisen, Stéphane Oudard, Cezary Szczylik et al. · JNCI Journal of the National Cancer Institute · 2008 · 136 citations · Full text

Medicine, Oncology, Pharmacology +17